Thyroid Antithyroid Drugs Dept of Pharmacology CIPS Introduction

  • Slides: 20
Download presentation
Thyroid & Antithyroid Drugs Dept. of Pharmacology, CIPS

Thyroid & Antithyroid Drugs Dept. of Pharmacology, CIPS

Introduction: • Thyroid releases T 3 & T 4 • The ratio of T

Introduction: • Thyroid releases T 3 & T 4 • The ratio of T 4 to T 3 is 5: 1, so most of the hormone released is thyroxine • Most of the T 3 in the blood is derived from thyroxine • T 3 is three to four times more potent than T 4 • The affinity of the receptor site for T 3 is about ten times higher than that for T 4 Physiological actions of thyroid hormones • To normalize growth and development, body temperature, and energy levels – Insufficiency→ cretinism (infant & child), and myxedema (adult); – Excess→hyperthyroid • To enhance CNS excitability & sensitivity of CVS to NA

Synthesis of thyroid hormones Thyroid hormones triiodothyronine (T 3) tetraiodothyronine (T 4, thyroxine) Materials

Synthesis of thyroid hormones Thyroid hormones triiodothyronine (T 3) tetraiodothyronine (T 4, thyroxine) Materials iodine & tyrosine Steps: 1. Iodide is trapped by sodium-iodide symporter 2. Iodide is oxidized by thyroidal peroxidase to iodine peroxidase 3. Tyrosine in thyroglobulin is iodinated and forms MIT & DIT 4. Iodotyrosines condensation MIT+DIT→T 3; DIT+DIT→T 4

hyperthyroid cretinism myxedema 8

hyperthyroid cretinism myxedema 8

Thyroid hormone activation of target cells: • Thyroxine (T 4) and triiodothyronine (T 3)

Thyroid hormone activation of target cells: • Thyroxine (T 4) and triiodothyronine (T 3) readily diffuse through the cell membrane. • Much of the T 4 is deiodinated to form T 3, which interacts with the thyroid hormone receptor, bound as a heterodimer with a retinoid X receptor, of the thyroid hormone response element of the gene. • This causes either increases or decreases in transcription of genes that lead to formation of proteins, thus producing the thyroid hormone response of the cell. • The actions of thyroid hormone on cells of several different systems are shown. m. RNA, messenger ribonucleic acid. Thyroid drugs Representative drugs • levothyroxine (L-T 4, levoxyl, synthroid) • liothyronine (T 3, cytomel, triostat) • liotrix (T 4 plus T 3) (euthyroid, thyrolar)

Pharmacokinetics • po easily absorbed; the bioavailablity of T 4 is 80%, and T

Pharmacokinetics • po easily absorbed; the bioavailablity of T 4 is 80%, and T 3 is 95%. • Drugs that induce hepatic microsomal enzymes (e. g. , rifampin, phenbarbital, phenytoin, and etc) improve their metabolism. • Levothyroxine is the choice drug for hypothyroidism • T 4 is converted to T 3 intracellularly so levothyroxine produces both hormones • If angina pectoris or cardiac arrhythmia develops, it is essential to stop thyroxine immediately Clinical use: 1. Hypothyroidism: cretinism & myxedema; 2. simple goiter: for pathogenisis remaining unclear Adverse reactions – Overmuch leads to thyrotoxicosis; – Angina or myocardial infarction usually appears in ageds

Thyroid Inhibitors: • Thyroid Inhibitors Drugs which are used to lower the functional capacity

Thyroid Inhibitors: • Thyroid Inhibitors Drugs which are used to lower the functional capacity of hyperactive thyroid gland – Thyrotoxicosis: Grave`s disease and toxic nodular goitre – Signs & Symptoms: Skin flushed, warm, moist muscles weak, Heart rate rapid, heart beat forceful, bounding arterial pulses ↑ energy expenditure & appetite, loss of weight, Insomnia, anxiety, heat intolerance, Diarrhea, Angina, arrhythmia and heart failure, Muscular wasting, thyroid myopathy – Untreated thyrotoxicosis - osteoporosis • Inhibit Hormone synthesis (Antithyroid Drugs): – Propylthiouracil, Carbimazole, Methimazole • Ionic Inhibitors: – Thiocyanates (-SCN), Perchlorates (-Cl. O 4), Nitrates (-NO 3) • Inhibits Hormone release: – Iodine, Iodides of Na and K, Organic Iodide • Destroy Thyroid tissue: Radioctive Iodine (131, 125, 123)

 • Antithyroid Drugs: • Reduce formation of thyroid hormone Inhibit oxidation and oraganifiction

• Antithyroid Drugs: • Reduce formation of thyroid hormone Inhibit oxidation and oraganifiction of iodine – bind to thyroid peroxidase Inhibit coupling of iodotyrosines to form T 4 and T 3 • Result in intrathyroidal iodine deficiency Maximum effect delayed until existing hormone stores exhausted • High dosage leads to hypothyroidism Propylthiouracil inhibits peripheral conversion of T 4 to T 3 at high doses used in thyroid storm • Propylthiouracil Vs Carbimazole : Propylthiouracil 1. 2. 3. 4. 5. 6. 7. Less potent Highly Plasma bound Less Placenta and milk entry T½ 1 -2 hrs No active metabolite Multiple dosing Inhibits T 4 to T 3 Carbimazole 5 times more potent Less bound High entry 6 -10 Hrs Active metabolite – methimazole Single dose No T 4 to T 3 inhibition

Pharmacokinetics: • Orally absorbed well, widely distributed in the body and crosses placenta and

Pharmacokinetics: • Orally absorbed well, widely distributed in the body and crosses placenta and enter milk Metabolized in liver and excreted in urine • All are concentrated in thyroid and intrathyroid t½ is longer • Preparation: PTU – 50 mg tabs. , Methimzole – 5 & 10 mg tbs. and Carbimzole – 2. 5/5 mg tabs. • Adverse effects : • Major : Agranulocytosis, Thrombocytopenia, Acute hepatic necrosis, Cholestatic hepatitis, Vasculitis, Lupus-like syndrome • Minor : Rashes, urticaria, arthralgia, fever, anorexia, nausea, taste and smell abnormalities • Monitor ADR: Blood disorder- first two months of treatment Routine leucocytes counts, Patient advised to stop drugs if symptoms of sore throat, fever, mouth ulcers develop and have leucocytes count performed If agranulocytosis develops – withdraw drug, hospitalization

Clinical uses : • Hyperthyroidism: Principal therapy Adjuvant to radioiodine to control disease •

Clinical uses : • Hyperthyroidism: Principal therapy Adjuvant to radioiodine to control disease • To prepare patient for surgery Clinical improvement 2 to 4 wk • Guide to therapy-decrease nervousness, palpitation, increase strength and weight gain and pulse rate • Optimal treatment- decreased gland size Iodine: • Iodine Iodide well absorbed • Selective uptake and 25 times conc. by thyroid • Iodide deficiency ↓ thyroid hormones Hyperplasia, increased vascularity and goiter • Effects related to dose and thyroid status • Hyperthyroidism- moderate excess of iodine ↑ synthesis • Substantial excess inhibits hormone release, promote storage, gland firm, vascularity ↓ Euthyroid

Clinical uses: • Large doses for thyroid crisis • Preparation for thyroidectomy KI 60

Clinical uses: • Large doses for thyroid crisis • Preparation for thyroidectomy KI 60 mg orally 8 hrly produces effects in 12 days, maximal 10 -24 days KI for 3 days to cover I 132 or I 123 isotopes • Prophylaxis of endemic cretinism –inj. Iodized oil IM 3 -5 years • Antiseptic on skin / surgical scrub, expectorant ADRs : • IODISM- metallic taste, hypersalivation, running eyes and nose, sore throat, cough, diarrhea, skin rashes • Prolonged use- goiter and myxoedema Goiter in asthmatics Neonatal hypothyroidism with topical iodine Flaring of acne

Radioiodine (I 131): • Swallowed I 131 trapped and conc. in thyroid follicles •

Radioiodine (I 131): • Swallowed I 131 trapped and conc. in thyroid follicles • 90 % Beta radiation (upto 0. 5 mm) • Gamma radiation- deep penetration • Radioactive half life 8 days • Used in diffuse toxic goiter (Thyrotoxicosis/Grave’s disease), toxic nodular goiter, thyroid carcinoma – Diagnosis of thyroid disorder • Contraindication- pregnancy, lactation, children • Beneficial effects within one month • Maximal effects – 3 months • Life long follow-up • Review at 6 weeks • Add antithyroid drugs and beta-blocker in relapsing thyrotoxicosis Disadvantages: : • Iodism • Hypothyroidism • Long latent period of response • Contraindicated in pregnncy • Young patients are contraindicated – lifelong therapy of T 4

Beta Blockers: • In hyerthyroidism - increased tissue sensitivity to catecholamine – Palpitation, tremor,

Beta Blockers: • In hyerthyroidism - increased tissue sensitivity to catecholamine – Palpitation, tremor, nervousness, sweating, myopathy and sweating • Increased second messenger c. AMP responses • Do not alter course of disease and thyroid function tests • Used in: – Preoperative therapy with Iodine – Awaiting response to carbimazole – Propranolol 20 – 80 mg 6 -8 Hrly Thyroid storm or crisis: • A sudden exacerbation of symptoms of thyrotoxicosis, characterized by fever, sweating, tachycardia, extreme nervous excitability, and pulmonary edema • Life-threatening emergency • Large amount of hormone into circulation occurs in untreated or incompletely treated patient. • Precipitated by infection, trauma, toxemia of pregnancy

Thyroid storm or Crisis - Treatment: • Inj. Propranolol IV, slow, 1 mg /

Thyroid storm or Crisis - Treatment: • Inj. Propranolol IV, slow, 1 mg / min. to max. 10 mg followed by 40 -80 mg oral every 8 Hrly • Propylthiouracil- large doses 300 -400 mg 4 -6 Hrly • Potassium Iodide 600 mg to 1 g orally in first 24 hr to inhibit hormone release or Ipanoic acid/ipodate (radioiodine) • Hydrocortisone 100 mg 8 Hrly IV followed by oral prednisolone • Hyperthermia – cooling and aspirin • Heart failure- conventional treatment – Diltiazem: 60 -120 mg BD oral Thyroid malfunction and Pregnancy • In a pregnant hypothyroid patient, it is extremely important that the dose of thyroxine be adequate. • This is because early development of the fetal brain depends on maternal thyroxine • If thyrotoxicosis occurs, propylthiouracil is used an elective subtotal thyroidectomy performed

Thank you

Thank you